Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model

被引:9
作者
Johansson, Anna [2 ,3 ]
Rudolfsson, Stina Haggstrom [1 ]
Kilter, Sigrid [2 ]
Bergh, Anders [2 ]
机构
[1] Umea Univ, Dept Surg & Perioperat Sci, S-90187 Umea, Sweden
[2] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden
[3] Western Australian Inst Med Res, Perth, WA, Australia
基金
瑞典研究理事会;
关键词
hypoxia; castration; tirapazamine; prostate; Dunning H; ENDOTHELIAL GROWTH-FACTOR; VENTRAL PROSTATE; BLOOD-FLOW; CELL-DEATH; INDUCIBLE FACTOR-1-ALPHA; STIMULATED GROWTH; FACTOR EXPRESSION; SOLID TUMORS; ANGIOGENESIS; PROGRESSION;
D O I
10.1111/j.1464-410X.2010.09690.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To explore the effects of castration therapy, the standard treatment for advanced prostate cancer, in relation to tumour hypoxia and to elicit its importance for the short-and long-term therapeutic response. MATERIAL AND METHODS We used the androgen-sensitive rat Dunning H prostate tumour model that transiently responds to castration treatment followed by a subsequent relapse, much like the scenario in human patients. Tumour tissues were analysed using stereological methods in intact, 1 and 7 days after castration therapy. RESULTS Hypoxia was transiently up-regulated after castration therapy and correlated with the induction of tumour cell apoptosis. When castration therapy was combined with tirapazamine (TPZ), a drug that targets hypoxic cells and the vasculature, the effects on tumour cell apoptosis and tumour volume were enhanced in comparison to either castration or TPZ alone. CONCLUSION The present study suggests that castration-induced tumour hypoxia is a novel target for therapy.
引用
收藏
页码:1818 / 1824
页数:7
相关论文
共 51 条
[1]   Hypoxia-inducible factors and hypoxic cell death in tumour physiology [J].
Bacon, AL ;
Harris, AL .
ANNALS OF MEDICINE, 2004, 36 (07) :530-539
[2]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[3]   Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype [J].
Butterworth, Karl T. ;
McCarthy, Helen O. ;
Devlin, Andrea ;
Ming, Louise ;
Robson, Tracy ;
McKeown, Stephanie R. ;
Worthington, Jenny .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (04) :760-768
[4]   Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer [J].
Cvetkovic, D ;
Movsas, B ;
Dicker, AP ;
Hanlon, AL ;
Greenberg, RE ;
Chapman, JD ;
Hanks, GE ;
Tricoli, JV .
UROLOGY, 2001, 57 (04) :821-825
[5]  
Durand RE, 2001, ACTA ONCOL, V40, P929
[6]   Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: A well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia [J].
Emmenegger, U ;
Morton, GC ;
Francia, G ;
Shaked, Y ;
Franco, M ;
Weinerman, A ;
Man, S ;
Kerbel, RS .
CANCER RESEARCH, 2006, 66 (03) :1664-1674
[7]   Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats [J].
Franck-Lissbrant, I ;
Häggström, S ;
Damber, JE ;
Bergh, A .
ENDOCRINOLOGY, 1998, 139 (02) :451-456
[8]   Novel syngeneic pseudo-orthotopic prostate cancer model:: vascular, mitotic and apoptotic responses to castration [J].
Frost, GI ;
Lustgarten, J ;
Dudouet, B ;
Nyberg, L ;
Hartley-Asp, B ;
Borgström, P .
MICROVASCULAR RESEARCH, 2005, 69 (1-2) :1-9
[9]  
Gao J, 2001, CANCER RES, V61, P5038
[10]   Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells [J].
Ghafar, MA ;
Anastasiadis, AG ;
Chen, MW ;
Burchardt, M ;
Olsson, LE ;
Xie, H ;
Benson, MC ;
Buttyan, R .
PROSTATE, 2003, 54 (01) :58-67